Precision Preclinical Models for Autoimmune & Inflammatory Drug Discovery
Inflammation & Immune Disease Models
Our Immunology & Inflammation Models
Inflammation and immune-related diseases arise from dysregulated immune responses, leading to conditions such as autoimmune disorders, chronic inflammation, and fibrosis. Understanding these complex conditions requires highly predictive preclinical models that accurately replicate human disease mechanisms.
Medicilon’s validated in vivo models offer clinically relevant insights, enabling researchers to decipher disease pathways to identify novel therapeutic targets, evaluate drug efficacy and immune modulation with precision, and assess disease progression to optimize treatment strategies. With a focus on accelerating therapeutic advancements, our models support the development of next-generation immunotherapies, biologics, and targeted treatments.
Clinically Predictive & Translational
Our models accurately mimic human immune system dysregulation, ensuring high translational relevance.
Customizable Study Designs
We tailor study parameters to your specific research needs, allowing for precise mechanistic and efficacy evaluations.
Supports Diverse Therapeutic Modalities
Ideal for biologics, immune modulators, targeted therapies, and small molecules.
Accelerated Preclinical Drug Development
Our efficient, reproducible models enable rapid and reliable preclinical insights, de-risking clinical progression.
Models for Inflammatory & Immune Diseases
Medicilon offer a diseases models for inflammatory and immune diseases, allowing researchers to accelerate therapeutic discovery and reduce clinical trial risks.
Inflammatory & Immune Models:
Animal Model
Disease
Diease Type
Animal Type
- Collagen-Induced Arthritis (CIA)
- Rheumatoid Arthritis (RA)
- Autoimmune Diseases
- Rats
- Adjuvant-Induced Arthritis (AIA)
- Rheumatoid Arthritis (RA)
- Autoimmune Diseases
- Rats
- Sodium Urate-induced Gouty Arthritis
- Rheumatoid Arthritis (RA)
- Autoimmune Diseases
- Rats
- MOG-Induced Experimental Autoimmune Encephalomyelitis (EAE)
- Multiple Sclerosis (MS)
- Autoimmune Diseases
- Mice
- Imiquimod-Induced Psoriasis
- Psoriasis
- Autoimmune Diseases
- Mice
- IL-23-Induced Auricle Psoriasis
- Psoriasis
- Autoimmune Diseases
- Mice
- Subacute Eczema Induced by DNFB
- Atopic Dermatitis (AD)
- Autoimmune Diseases
- Mice
- Chronic Atopic Dermatitis Induced by DNFB
- Atopic Dermatitis (AD)
- Autoimmune Diseases
- Mice
- Atopic Dermatitis induced by MC903
- Atopic Dermatitis (AD)
- Autoimmune Diseases
- Mice
- TNBS-Induced Ulcerative Colitis
- Inflammatory Bowel Disease (IBD)
- Autoimmune Diseases
- Rats
- DSS-Induced Mouse Ulcerative Colitis
- Inflammatory Bowel Disease (IBD)
- Autoimmune Diseases
- Mice
- Pig Serum-Induced Hepatic Fibrosis
- Hepatic Fibrosis
- Immune-Mediated Inflammatory Conditions
- Rats
- LPS-Induced Pneumonia
- Respiratory Diseases
- Immune-Mediated Inflammatory Conditions
- Mice
- Bleomycin-Induced Pulmonary Fibrosis
- Respiratory Diseases
- Immune-Mediated Inflammatory Conditions
- Rats
- OVA-Induced Asthma
- Respiratory Diseases
- Immune-Mediated Inflammatory Conditions
- Rats
- HDM (House Dust Mite)-induced Asthma
- Respiratory Diseases
- Immune-Mediated Inflammatory Conditions
- Mice
- MSU induced Peritonitis Disease
- Acute Inflammatory Disease
- Immune-Mediated Inflammatory Conditions
- Mice
Partner with Medicilon for Preclinical Inflammation Studies
At Medicilon, we go beyond providing models, we collaborate with researchers to refine therapeutic strategies, accelerate drug discovery timelines, and enhance the success of immunotherapies.
Our state-of-the-art facilities and expert immunology team deliver high-quality, impactful data to support your drug development pipeline.
How Orthotopic Models Power Cancer Research
Key Models highlights
- Testing Drug Efficacy in a Natural Tumor Environment: Get accurate data on tumor growth inhibition, drug penetration, and therapeutic impact.
- Metastasis Research: Study how cancer spreads, test anti-metastatic therapies, and track tumor dissemination in real-time.
- Combination Therapy Development: Evaluate the effectiveness of multi-drug regimens and optimize treatment strategies.
- Immune System & Tumor Microenvironment Studies: Explore how tumors interact with immune cells, aiding in the development of immunotherapies.
Tumor
Neurological disease
Digestive system disease
Metabolic disease
Cardiovascular diseases
Inflammatory & immune disease
Other disease models
Let’s Drive Immuno-Oncology Innovation - Together
At Medicilon, we don’t just offer models – we provide end-to-end support for your oncology research. Our team of highly experienced scientists and cutting-edge facilities ensure:
- Fast, high-quality study execution to keep your research moving forward.
- Data-driven insights for more informed decision-making.
- Customized research solutions tailored to your specific drug development needs.
Tumor Models
Non-tumor Models
cancer therapy INNOVATION
Integration Across Oncology Models
Medicilon provides a full suite of preclinical models, ensuring a smooth transition between different research phase.
Tumor models:
Medicilon provides a comprehensive range of oncology models, including:
- CDX Models – Rapid, cost-effective screening for early-phase drug development.
- PDX Models – Clinically relevant, patient-matched models for personalized therapy research.
- Orthotopic Models – Study tumor progression in its native environment for improved therapeutic evaluation.
- Humanized Mouse Models – Bridge the gap between preclinical and clinical immunotherapy studies.
By leveraging syngeneic models alongside other in vivo platforms, researchers can refine drug candidate selection, reduce clinical trial failure rates, and accelerate the path to breakthrough therapies.
